Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Liquidia Technologies Receives $3 Million In Funding Through U.S. Commerce Department’s National Institute Of Standards And Technology

Abstract:
Funding Will Enhance Liquidia's PRINT® Manufacturing Process

Liquidia Technologies Receives $3 Million In Funding Through U.S. Commerce Department’s National Institute Of Standards And Technology

Research Triangle Park, NC | Posted on December 18th, 2009

Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department's National Institute of Standards and Technology (NIST) to further develop and scale‐up the company's PRINT manufacturing process. As part of its Technology Innovation Program (TIP), NIST announced it will fund new cost‐sharing projects to support innovative technologies that address critical national needs.

"We are very excited to have been selected by NIST as one of the 20 projects to receive funding through the TIP program," said Tom Templeman, Senior Vice President, Integrated Supply Chain at Liquidia. "This investment will support our continued development of PRINT manufacturing, which will allow us to develop clinically relevant quantities of particles for innovative vaccines and therapeutics."

The PRINT manufacturing process uses a proprietary roll‐to‐roll method that allows Liquidia to produce precisely engineered particles, which offer safer and more efficient delivery of vaccine and therapeutic drug products. The capabilities realized as a direct result of this project will support the advancement of a platform of products, including the company's initial vaccine product which is expected to enter clinical trials next year.

"As an industry, we are on the cusp of great therapeutic advancements in areas where unmet medical needs still persist," said Neal Fowler, CEO of Liquidia Technologies. "An investment such as this plays a critical role in enabling Liquidia to advance innovative products to the next stage of development where we will begin to see the true potential for patients."

####

About Liquidia Technologies
Liquidia Technologies is a privately‐held nanotechnology company that develops and manufactures precisely engineered particles for improved delivery of biological and small molecule therapeutics. The company is currently advancing products within the fields of vaccines, nucleic acid delivery, and inhaled therapeutics to address critical unmet needs in the treatment of human disease. The company was founded in 2004 and is located in Research Triangle Park, North Carolina.

For more information, please click here

Contacts:
Elle Pishny
919‐328‐4361

Copyright © Liquidia Technologies

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

'Exotic' material is like a switch when super thin April 18th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Govt.-Legislation/Regulation/Funding/Policy

'Exotic' material is like a switch when super thin April 18th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Novel stapled peptide nanoparticle combination prevents RSV infection, study finds April 17th, 2014

INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

Nanomedicine

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014

Announcements

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

'Exotic' material is like a switch when super thin April 18th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Nanobiotechnology

Targeting cancer with a triple threat: MIT chemists design nanoparticles that can deliver three cancer drugs at a time April 15th, 2014

Biologists Develop Nanosensors to Visualize Movements and Distribution of Plant Stress Hormone April 15th, 2014

In latest generation of tiny biosensors, size isn't everything: UCLA researchers overturn conventional wisdom on nanowire-based diagnostic devices April 11th, 2014

Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE